Search results
Bird Flu Keeps Spreading in U.S. Cows. 5 Big Questions, Answered.
Barrons.com· 10 hours agoStill, the federal government is ramping up the cadence of its response, and is preparing stockpiled...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 6 days agoFEATURE Moderna and Pfizer are in talks with the federal government over a potential avian flu...
IRLAB has Administered the First Dose in a Phase I Clinical Trial with the Drug Candidate IRL757
Morningstar· 7 days agoIRL757 has been shown in preclinical disease models to counteract apathy - a condition that impairs the quality of life for millions of people with Parkinson's disease and ...
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 5 days agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company announced it was pulling the vaccine ...
Free COVID-19 vaccines could be a thing of the past. Experts weigh in.
USA TODAY via Yahoo News· 7 days agoPeople in this category likely would have had difficulty getting a COVID-19 vaccine without Bridge...
Vaccine makers receive stock boost after third human bird flu case in US
Newsweek· 5 days agoShares in some companies that produce vaccines have seen stock boosts following a small number of...
Uncover the Hidden Data on This Medical Procedure in Children
Mercola· 7 days ago“They do not publish the results [or] let any independent scientist in to look at that information,” Brian Hooker, chief scientific officer for Children’s Health Defense, said. In 1962, children received just five vaccine doses.
EXCLUSIVE: Coya Therapeutics, Focused On Neurodegenerative Diseases Has Gained 70% Since IPO; CEO...
Benzinga via Yahoo Finance· 1 day agoCoya Therapeutics Inc (NASDAQ:COYA) is a clinical-stage biotechnology company developing treatments...
Texas cities and counties are destroying expired Narcan. Some say it could still be used to save...
KRGV Rio Grande Valley· 1 day agoSign up for The Brief, The Texas Tribune’s daily newsletter that keeps readers up to speed on the...
AMGEN TO PRESENT INNOVATIVE RESEARCH FROM ITS ROBUST ONCOLOGY PORTFOLIO AT ASCO 2024
WKBN 27 Youngstown· 10 hours agoAmgen (NASDAQ:AMGN) today announced the presentation of new data from its broad oncology portfolio at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting, taking place from ...